Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor

NCT06057571 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholangiocarcinoma Metastatic

Interventions

DRUG: TT-00420 (tinengotinib)

Sponsor

TransThera Sciences (Nanjing), Inc.